IL33 and multiple sclerosis: In addition, increased levels of IL-33 are detected in patients with multiple sclerosis (MS) (140), systemic lupus erythematous (SLE) (141), type 1 diabetes (T1D) (142) and rheumatoid arthritis (RA) (143).